Oversight of opioid advertising in Canada remains lax despite new federal guidance.

Oversight of opioid advertising in Canada remains lax despite new federal guidance. CMAJ. 2018 Jun 11;190(23):E730-E731 Authors: Webster P PMID: 29891483 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/29891483?dopt=Abstract

Source: cmaj - June 11, 2018 Category: General Medicine Authors: Webster P Tags: CMAJ Source Type: research

More News: Advertising | Canada Health | General Medicine